Postprandial Lipemia and Endothelial Function in ACCORD- Ancillary to ACCORD

首次发布于 2002 年 5 月 17 日

Action to Control Cardiovascular Risk in Diabetes (ACCORD)

计划入组 10,251 人 · 首次发布于 1999 年 10 月 28 日

Blincyto Amgen Acrotech BioPharma PH2 Blincyto Marqibo R/R Philadelphi CD19+ ALL

首次发布于 2020 年 6 月 26 日

Teriparatide biosimilar(Accord Healthcare S.L.U.)

Encochleated amphotericin B (Matinas BioPharma)

NeuGene (AVI BioPharma)

Accord Biopharma, Inc.

United States

Accord Healthcare Inc

Canada

ACCORD HEALTHCARE SL

Spain

Accord BioPharma Launches IMULDOSA Biosimilar at 92% Discount to STELARA

Intas Pharmaceuticals and Accord BioPharma Acquire UDENYCA Biosimilar, Expanding Global Pegfilgrastim Market Presence

Accord BioPharma's Hercessi (trastuzumab-strf) Receives FDA Approval for 420mg Strength